2004/710/EC: Decision of the European Parliament of 21 April 2004 concerning discharge to the Director of the European Agency for the Evaluation of Medicinal Products in respect of the implementation of its budget for the financial year 2002 
Decision of the European Parliament 
of 21 April 2004 
concerning discharge to the Director of the European Agency for the Evaluation of Medicinal Products in respect of the implementation of its budget for the financial year 2002 
(2004/710/EC) 
THE EUROPEAN PARLIAMENT, 
having regard to the Court of Auditors' report on the financial statements of the European Agency for the Evaluation of Medicinal Products for the financial year 2002, together with the Agency's replies [1] (C5-0638/2003), 
having regard to the Council's recommendation of 9 March 2004 (C5-0143/2004), 
having regard to the EC Treaty, and in particular Article 276 thereof, 
having regard to Council Regulation (EC, Euratom) No 1605/2002 of 25 June 2002 on the Financial Regulation applicable to the general budget of the European Communities [2], and in particular Article 185 thereof, and to Council Regulation (EC) No 1647/2003 of 18 June 2003 amending Regulation (EEC) No 2309/93 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products [3], and in particular Article 57a thereof, 
having regard to Commission Regulation (EC, Euratom) No 2343/2002 of 19 November 2002 on the framework Financial Regulation for the bodies referred to in Article 185 of Council Regulation (EC, Euratom) No 1605/2002 on the Financial Regulation applicable to the general budget of the European Communities [4], and in particular Article 94 thereof, 
having regard to Rule 93a of and Annex V to its Rules of Procedure, 
having regard to the Report of the Committee on Budgetary Control and the opinion of the Committee on the Environment, Public Health and Consumer Policy (A5-0212/2004), 
1. Gives discharge to the Director of the European Agency for the Evaluation of Medicinal Products, in respect of the implementation of its budget for the financial year 2002; 
2. Records its comments in the accompanying resolution; 
3. Instructs its President to forward this decision and the accompanying resolution to the Director of the European Agency for the Evaluation of Medicinal Products, the Council, the Commission and the Court of Auditors and to have them published in the Official Journal of the European Union (L series). 
The Secretary-General 
Julian Priestley 
The President 
Pat Cox 
[1] OJ C 319, 30.12.2003, p. 22. 
[2] OJ L 248, 16.9.2002, p. 1. 
[3] OJ L 245, 29.9.2003, p. 19. 
[4] OJ L 357, 31.12.2002, p. 72. 
-------------------------------------------------- 
